rosiglitazone has been researched along with alpha-chymotrypsin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, ML; Blanchard, PG; Caron, A; Castro, É; Côté, M; Deshaies, Y; Dias, FA; Festuccia, WT; Gélinas, Y; Guerra-Sá, R; Moreira, RJ; Oliveira, TE; Ortiz-Silva, M; Peixoto, AS | 1 |
1 other study(ies) available for rosiglitazone and alpha-chymotrypsin
| Article | Year |
|---|---|
PPARγ is a major regulator of branched-chain amino acid blood levels and catabolism in white and brown adipose tissues.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Amino Acids, Branched-Chain; Animals; Chymotrypsin; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Triglycerides | 2018 |